-
Mapping the GIS to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Gout
Mar 10, 2025, 14:00 PM -
Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Mar 10, 2025, 14:00 PM -
Measuring Patient Engagement: The Importance of a Framework
Mar 10, 2025, 14:00 PM -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)
Mar 10, 2025, 14:00 PM -
Systematic Literature Review of the Economic Burden of Illness in Advanced or Metastatic Non-Small Cell Lung Cancer in First-Line
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness And Value of Information Analyses of Sotorasib Versus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Mar 10, 2025, 14:00 PM -
The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China
Mar 10, 2025, 14:00 PM -
Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants
Mar 10, 2025, 14:00 PM -
Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States
Mar 10, 2025, 14:00 PM -
Heredofamilial Amyloidosis Due to Transthyretin (hATTR): Cost Analysis From the Perspective of the Public Health Sector in Mexico
Mar 10, 2025, 14:00 PM -
Time Toxicity of Bispecific Antibody (BsAb) Options in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Fixed-Duration Mosunetuzumab Versus Treat to Progression Epcoritamab
Mar 10, 2025, 14:00 PM -
Early Health Outcomes Model on the Impact of Trimodulin in the Management of Patients With Severe Community-Acquired Pneumonia on Invasive Mechanical Ventilation Based on the CIGMA Phase 2 Randomized Placebo-Controlled Trial
Mar 10, 2025, 14:00 PM -
Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention
Mar 10, 2025, 14:00 PM -
Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Extraction of Pulmonary Function Test Results from Unstructured Clinical Notes using a Retrieval-Augmented Generation Approach on a Major Cloud Platform
Mar 10, 2025, 14:00 PM -
Pre-Diagnostic Healthcare for People with Fragile X Syndrome
Mar 10, 2025, 14:00 PM -
Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Pembrolizumab in Patients Diagnosed with Non-Small Cell Lung Cancer: A Real-World Study in a Colombian Health Insurance Provide
Mar 10, 2025, 14:00 PM
